非编码RNA在脓毒症及脓毒症相关器官功能障碍中的调控作用:一项更新的系统评价
该更新系统评价聚焦2016年10月1日至2022年3月31日PubMed数据库中关于非编码RNA与脓毒症及脓毒症相关器官功能障碍(SAOD)的研究,纳入537项原始研究。近5年实验研究证实长链非编码RNA在脓毒症及SAOD中具有重要调控作用,而环状RNA与脓毒症的研究仍有限。研究采用改良的SYRCLE指南评估质量,SYRCLE评分范围为3至7分(平均3.78分)。94种非编码RNA被评估为脓毒症潜在生物标志物,117项研究显示非编码RNA可作为脓毒症及SAOD的潜在治疗靶点;分子层面研究最多的是炎症相关通路、线粒体功能障碍、细胞凋亡和/或氧化应激。
要点
- 该系统评价纳入537项原始研究,聚焦近5年(2016年10月1日至2022年3月31日)非编码RNA与脓毒症及脓毒症相关器官功能障碍(SAOD)的关系。
- 94种非编码RNA被评估为脓毒症潜在生物标志物,但敏感性、特异性和受试者工作特征曲线的选择性报告较为常见。
- 117项研究显示非编码RNA可作为脓毒症及SAOD的潜在治疗靶点。
- 纳入研究的SYRCLE评分范围为3至7分,平均3.78分。
- 环状RNA与脓毒症的研究仍有限,需要更多研究来阐明这一关系。
适用人群与场景
- 研究纳入探讨非编码RNA在脓毒症发病机制中作用、或作为脓毒症生物标志物或治疗靶点的原始研究。
研究设计与关键结果
- 共537项原始研究探讨非编码RNA在脓毒症及SAOD中的潜在作用。
- 近5年实验研究证实长链非编码RNA在脓毒症及SAOD中具有重要调控作用。
- 环状RNA与脓毒症的研究仍有限,需要更多研究来阐明这一关系。
- 纳入研究的SYRCLE评分范围为3至7分(平均3.78分)。
- 94种非编码RNA被评估为脓毒症潜在生物标志物,敏感性、特异性和受试者工作特征曲线的选择性报告较为常见。
- 117项研究显示非编码RNA可作为脓毒症及SAOD的潜在治疗靶点。
- 分子层面研究最多的是炎症相关通路、线粒体功能障碍、细胞凋亡和/或氧化应激。
证据类型、等级与局限
- 证据类型:更新的系统评价。
- 质量评估:采用改良的SYRCLE指南评估研究质量,SYRCLE评分范围为3至7分(平均3.78分)。
- 局限性:环状RNA与脓毒症的研究仍有限;敏感性、特异性和受试者工作特征曲线的选择性报告较为常见;作者建议开展前瞻性、大规模、多中心队列研究以评估特定非编码RNA作为生物标志物并测试其作为治疗靶点时的器官特异性递送。
对床旁实践的改变
- 作者认为非编码RNA可能是脓毒症及SAOD的良好生物标志物和治疗候选靶点。
- 作者建议开展前瞻性、大规模、多中心队列研究,以评估特定非编码RNA作为生物标志物,并在其作为治疗靶点时测试这些调控分子的器官特异性递送。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: The exact molecular mechanisms underlying sepsis remain unclear. Accumulating evidence has shown that noncoding RNAs (ncRNAs) are involved in sepsis and sepsis-associated organ dysfunction (SAOD). Methods: We performed this updated systematic review focusing mainly on research conducted in the last 5 years regarding ncRNAs associated with sepsis and SAOD. The following medical subject headings were used in the PubMed database from October 1, 2016, to March 31, 2022: "microRNA," "long noncoding RNA," "circular RNA," "sepsis," and/or "septic shock." Studies investigating the role of ncRNAs in the pathogenesis of sepsis and as biomarkers or therapeutic targets in the disease were included. Data were extracted in terms of the role of ncRNAs in the pathogenesis of sepsis and their applicability for use as biomarkers or therapeutic targets in sepsis. The quality of the studies was assessed using a modified guideline from the Systematic Review Center for Laboratory Animal Experimentation. Results: A total of 537 original studies investigated the potential roles of ncRNAs in sepsis and SAOD. Experimental studies in the last 5 years confirmed that long ncRNAs have important regulatory roles in sepsis and SAOD. However, studies on circular RNAs and sepsis remain limited, and more studies should be conducted to elucidate this relationship. Among the included studies, the Systematic Review Center for Laboratory Animal Experimentation scores ranged from 3 to 7 (an average score of 3.78). Notably, 94 ncRNAs were evaluated as potential biomarkers for sepsis, and selective reporting of the sensitivity, specificity, and receiver operating characteristic curve was common. A total of 117 studies demonstrated the use of ncRNAs as potential therapeutic targets in sepsis and SAOD. At a molecular level, inflammation-related pathways, mitochondrial dysfunction, cell apoptosis, and/or oxidative stress were the most extensively studied. Conclusion: This review suggests that ncRNAs could be good biomarkers and therapeutic candidates for sepsis and SAOD. Prospective, large-scale, and multicenter cohort studies should be performed to evaluate specific ncRNAs as biomarkers and test the organ-specific delivery of these regulatory molecules when used as therapeutic targets.
参考来源
- Zhang T, Yang YH, Liu YP, et al. REGULATORY ROLE OF NONCODING RNA IN SEPSIS AND SEPSIS-ASSOCIATED ORGAN DYSFUNCTION: AN UPDATED SYSTEMATIC REVIEW. Shock. 2022. PMID: 36155389. doi:10.1097/SHK.0000000000002000
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。